Peter Attia· MD
I think the scale would be one. We just can't when you do a combination in mice, you've got four groups and I think we if we had more money, we could design sort of multiffactoral clinical studies and pre-clinical studies where we're testing many compounds at the same time. We're sort of doing nested groups, you know, and and we could get a indication for things that actually could be additive together. Uh not just things that are working on their own.